Publications by authors named "John R Ingram"

Claim this Profile
M
Management of hidradenitis suppurativa in UK primary care: a cross-sectional survey.
Hannah E Wainman, Stephanie Gallard, Matthew J Ridd, John R Ingram

BJGP Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of standardized definitions and a core set of outcome characteristics following hidradenitis suppurativa surgery developed by an expert Delphi consensus.
Linnea L Westerkam, Hessel H van der Zee, Falk G Bechara, Stephanie Goldberg, Gregor B Jemec, John R Ingram

J Am Acad Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bimekizumab Pain Outcomes in Patients with Hidradenitis Suppurativa: Pooled 48-Week Results from BE HEARD I&II Phase 3 Randomized Clinical Trials.
John R Ingram, Hideki Fujita, Alice B Gottlieb, Hadar Lev-Tov, Errol Prens

Pain Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review of the use of the Dermatology Life Quality Index in routine clinical practice: evidence from 287 articles across 56 countries.
Jui Vyas, Jeffrey R Johns, Anjali Trivedi, Faraz M Ali, John R Ingram

Clin Exp Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Hidradenitis Suppurativa Symptom and Impact Diary: Development and psychometric evaluation of a novel set of patient-reported outcomes for hidradenitis suppurativa.
John R Ingram, Magdalena B Wozniak, Anna Passera, Lorenz Uhlmann, Angela Llobet Martinez

Br J Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HIdradenitis suppurativa DrainagE (HIDE) scale: development and content validation of a patient reported outcome measure.
Linnea Thorlacius, Bente Villumsen, Barry M McGrath, Kari Zalik, Susanne de Goeij, John R Ingram

Br J Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards the development of upgrade criteria for the treatment of hidradenitis suppurativa with biologics.
Georgios Nikolakis, Erkan Alpsoy, Monika Arenbergerova, Falk G Bechara, Farida Benhadou, John R Ingram

J Eur Acad Dermatol Venereol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bimekizumab demonstrated a favorable safety profile and high levels of efficacy with up to 2 years of treatment in patients with moderate to severe hidradenitis suppurativa: Pooled results from two phase 3 randomized, controlled trials and their open-label extension.
Christopher J Sayed, Brian Kirby, Amit Garg, Haley B Naik, Alexa B Kimball, John R Ingram

J Am Acad Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa: A Consensus Exercise Using a Modified Delphi Approach.
Amit Garg, Andrew Strunk, Bria Midgette, Kelly Frasier, Erica Cohn, John R Ingram

JAMA Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards a Paradigm Shift in Delivering Hidradenitis Suppurativa Care: a Narrative Review.
Falk G Bechara, Angelo V Marzano, Antonio Martorell, Hessel H van der Zee, Valeria Jordan M, John R Ingram

Dermatol Ther (Heidelb)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bimekizumab Impact on Patient-Reported Outcomes in Patients with Moderate to Severe Hidradenitis Suppurativa: Pooled 48-Week Results from BE HEARD I&II.
Vivian Y Shi, John R Ingram, Hadar Lev-Tov, Sylke Schneider-Burrus, Seth Forman

Dermatol Ther (Heidelb)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of psychiatric disease and treatment on biologic drug survival in patients with hidradenitis suppurativa.
Nikolaj Holgersen, Valdemar Wendelboe Nielsen, Hans-Christian Ring, John R Ingram, Jacob P Thyssen

J Am Acad Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Hidradenitis Suppurativa: A Meta-Analysis of Global Hidradenitis Suppurativa Atlas Studies.
Dorra Bouazzi, Sabrina M Nielsen, Paa G Hagan, Sofia Botvid, Lone S Hove, John R Ingram

JAMA Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil Extracellular Traps Are Widely Distributed Across Lesional and Perilesional Hidradenitis Suppurativa Skin, and Elevated Serum NET Markers Associate With Moderate to Severe HS Disease.
Stephanie C M van Dalen, Josephine W J Stein, Tirza Bruurmijn, Martyn L Foster, Renato G S Chirivi, John R Ingram

Int J Dermatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there still a role for clindamycin and rifampicin in the treatment of hidradenitis suppurativa? A review of the literature.
Hannah E Wainman, Eliza Hutchison, Niamh T McSwiney, Ayesha Shahid, Emmanuel Toni, John R Ingram

Clin Exp Dermatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Long-Term Pain Reduction with Secukinumab in Moderate to Severe Hidradenitis Suppurativa: A Post Hoc Analysis of the SUNSHINE and SUNRISE Phase 3 Trials.
John R Ingram, Jacek C Szepietowski, Lukasz Matusiak, Georgios Kokolakis, Magdalena B Wozniak

Dermatol Ther (Heidelb)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A qualitative interview study exploring patients' views and experiences of treatment for hidradenitis suppurativa in the UK.
Laura Howells, Paul Leighton, Kim S Thomas, Fiona Collier, Angela Gibbons, John R Ingram

Br J Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometric validation and interpretation thresholds of the Hidradenitis Suppurativa Quality of Life (HiSQOL©) questionnaire using pooled data from the phase III BE HEARD I & II trials of bimekizumab in hidradenitis suppurativa.
Joslyn S Kirby, Linnea Thorlacius, Jérémy Lambert, Valerie Ciaravino, Robert Rolleri, John R Ingram

Br J Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hidradenitis Suppurativa Symptom Daily Diary (HSSDD) and Questionnaire (HSSQ): Psychometric Validation and Interpretation Threshold Derivation Using Phase 3 Study Data.
John R Ingram, Jérémy Lambert, Valerie Ciaravino, Robert Rolleri, Ingrid Pansar

Dermatol Ther (Heidelb)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple sclerosis greatly impacts family members/partners: Evidence using the Family Reported Outcome Measure (FROM-16).
Rubina Shah, Sam Salek, Faraz M Ali, Kennedy Otwombe, Stuart J Nixon, Gillian Ingram, John R Ingram

Mult Scler J Exp Transl Clin· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic insights into ruxolitinib cream for mild hidradenitis suppurativa.
John R Ingram

Br J Dermatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The UK-Irish Atopic eczema Systemic TherApy Register (A-STAR): baseline characteristics of the cohort.
Elizaveta Gribaleva, Kaitlyn Chan, Carlos Chivardi, David Prieto-Merino, Man Fung Tsoi, John R Ingram

Br J Dermatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hidradenitis suppurativa: BJD state-of-the-art review series.
John R Ingram

Br J Dermatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation Science to Improve the Diagnosis and Management of Hidradenitis Suppurativa: HELyx Study Design Overview.
John R Ingram, Georgios Kokolakis, Barry M McGrath, Marco Romanelli, Falk G Bechara

Dermatol Ther (Heidelb)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing maximum and average numerical rating scale pain scores in hidradenitis suppurativa.
Yiwen H Li, Patrick Speck, John R Ingram, Lauren A V Orenstein

Arch Dermatol Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis